Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

May 01, 1997; Volume 281,Issue 2

ANALGESIA AND DRUGS OF ABUSE

  • You have access
    Mechanism of Attenuation of Morphine Antinociception by Chronic Treatment with l-Arginine
    Hemendra N. Bhargava, Jing-Tan Bian and Shailendra Kumar
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 707-712;
  • You have access
    Pharmacodynamics and Tolerance Development During Multiple Intravenous Bolus Morphine Administration in Rats
    Danièle M.-C. Ouellet and Gary M. Pollack
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 713-720;
  • You have access
    Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord
    George Pugh, David J. Mason, Vera Combs and Sandra P. Welch
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 730-737;
  • You have access
    Almost Complete Protection from [Met5]-Enkephalin-Arg6-Gly7-Leu8(Met-enk-RGL) Hydrolysis in Membrane Preparations by the Combination of Amastatin, Captopril and Phosphoramidon
    Toyokazu Hiranuma, Kayoko Iwao, Ken Kitamura, Teruhiko Matsumiya and Tetsuo Oka
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 769-774;
  • You have access
    Changes in Sensitivity to the Rate-Decreasing Effects of Opioids in Pigeons Treated Acutely or Chronically with l-α-Acetylmethadol
    Lisa R. Gerak and Charles P. France
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 799-809;
  • You have access
    M1 Receptor Agonist Activity Is Not a Requirement for Muscarinic Antinociception
    Malcolm J. Sheardown, Harlan E. Shannon, Michael D. B. Swedberg, Peter D. Suzdak, Frank P. Bymaster, Preben H. Olesen, Charles H. Mitch, John S. Ward and Per Sauerberg
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 868-875;
  • You have access
    Butylthio[2.2.2] (NNC 11–1053/LY297802): An Orally Active Muscarinic Agonist Analgesic
    Michael D. B. Swedberg, Malcolm J. Sheardown, Per Sauerberg, Preben H. Olesen, Peter D. Suzdak, Kristian T. Hansen, Frank P. Bymaster, John S. Ward, Charles H. Mitch, David O. Calligaro, Neil W. Delapp and Harlan E. Shannon
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 876-883;
  • You have access
    Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity
    Harlan E. Shannon, Malcolm J. Sheardown, Frank P. Bymaster, David O. Calligaro, Neil W. Delapp, Jaswant Gidda, Charles H. Mitch, Barry D. Sawyer, Peter W. Stengel, John S. Ward, David T. Wong, Preben H. Olesen, Peter D. Suzdak, Per Sauerberg and Michael D. B. Swedberg
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 884-894;
  • You have access
    An Antisense Oligonucleotide on the MouseShaker-like Potassium Channel Kv1.1 Gene Prevents Antinociception Induced by Morphine and Baclofen
    Nicoletta Galeotti, Carla Ghelardini, Laura Papucci, Sergio Capaccioli, Alessandro Quattrone and Alessandro Bartolini
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 941-949;

AUTONOMIC PHARMACOLOGY

  • You have access
    Effects of Adrenergic, Cholinergic and Ganglionic Blockade on Acute Depressor Responses to Metformin in Spontaneously Hypertensive Rats
    Martin S. Muntzel, Ayat Abe and Jørgen S. Petersen
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 618-623;
  • You have access
    Evidence for Spare Nicotinic Acetylcholine Receptors and a β4 Subunit in Bovine Adrenal Chromaffin Cells: Studies using Bromoacetylcholine, Epibatidine, Cytisine and mAb35
    Bryan W. Wenger, Darrell L. Bryant, R. Thomas Boyd and Dennis B. McKay
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 905-913;

BEHAVIORAL PHARMACOLOGY

  • You have access
    Central Serotonergic Systems in the Spontaneously Hypertensive and Lewis Rat Strains that Differ in the Elevated Plus-Maze Test of Anxiety
    Alexander Kulikov, Sylvie Aguerre, Olivier Berton, Andre Ramos, Pierre Mormede and Francis Chaouloff
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 775-784;
  • You have access
    N-Methyl-d-Aspartate Receptors in Associative Eyeblink Conditioning: Both MK-801 and Phencyclidine Produce Task- and Dose-Dependent Impairments
    Lucien T. Thompson and John F. Disterhoft
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 928-940;

CARDIOVASCULAR PHARMACOLOGY

  • You have access
    The Peripheral Action of Clonidine Analog ST-91: Involvement of Atrial Natriuretic Factor
    Jolanta Gutkowska, Suhayla Mukaddam-Daher and Johanne Tremblay
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 670-676;
  • You have access
    Nonpeptide Glycoprotein IIb/IIIa Inhibitors. 15. Antithrombotic Efficacy of L-738,167, a Long-Acting GPIIb/IIIa Antagonist, Correlates with Inhibition of Adenosine Diphosphate-Induced Platelet Aggregation but not with Bleeding Time Prolongation
    Jacquelynn J. Cook, Gary R. Sitko, Marie A. Holahan, Maria T. Stranieri, Joan D. Glass, Ben C. Askew, Charles J. McIntyre, David A. Claremon, John J. Baldwin, George D. Hartman, Robert J. Gould and Joseph J. Lynch
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 677-689;
  • You have access
    RPR 107393, a Potent Squalene Synthase Inhibitor and Orally Effective Cholesterol-Lowering Agent: Comparison with Inhibitors of HMG-CoA Reductase
    Dilip Amin, Ruth Z. Rutledge, Saul N. Needle, Helen F. Galczenski, Kent Neuenschwander, Anthony C. Scotese, Martin P. Maguire, Ray C. Bush, Dave J. Hele, Glenda E. Bilder and Mark H. Perrone
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 746-752;

CELLULAR AND MOLECULAR PHARMACOLOGY

  • You have access
    Novel Cyclic Peptide Agonist of High Potency and Selectivity for the Type II Vasoactive Intestinal Peptide Receptor
    Menghang Xia, Sunil P. Sreedharan, David R. Bolin, Gary O. Gaufo and Edward J. Goetzl
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 629-633;
  • You have access
    Vasodilator Action of Calcium Antagonists in Coronary ArteriesIn Vitro
    Stanley Kalsner
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 634-642;
  • You have access
    Activation of the Metabotropic Glutamate Receptor mGluR5 Prevents Glutamate Toxicity in Primary Cultures of Cerebellar Neurons
    Carmina Montoliu, Marta Llansola, Carmen Cucarella, Santiago Grisolía and Vicente Felipo
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 643-647;
  • You have access
    Agonist-Independent Effect of an Allosteric Enhancer of the A1 Adenosine Receptor in CHO Cells Stably Expressing the Recombinant Human A1 Receptor
    C. A. Kollias-Baker, J. Ruble, M. Jacobson, J. K. Harrison, M. Ozeck, J. C. Shryock and L. Belardinelli
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 761-768;
  • You have access
    Effects of Cadmium and Nisoldipine on the Delayed Rectifier Potassium Current in Guinea Pig Ventricular Myocytes
    Pascal Daleau, Majed Khalifa and Jacques Turgeon
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 826-833;
  • You have access
    Amantadine Inhibits Nicotinic Acetylcholine Receptor Function in Hippocampal Neurons
    Hiroaki Matsubayashi, Karen L. Swanson and Edson X. Albuquerque
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 834-844;

DRUG METABOLISM AND DISPOSITION

  • You have access
    Studies on the Metabolic Activation of Disulfiram in Rat. Evidence for Electrophilic S-Oxygenated Metabolites as Inhibitors of Aldehyde Dehydrogenase and Precursors of UrinaryN-Acetylcysteine Conjugates
    Pei Hu, Lixia Jin and Thomas A. Baillie
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 611-617;
  • You have access
    Catalysis of the Cysteine Conjugation and Protein Binding of Acetaminophen by Microsomes from a Human Lymphoblast Line Transfected with the cDNAs of Various Forms of Human Cytochrome P450
    Lingxiang Zhou, Richard R. Erickson, James P. Hardwick, Sang S. Park, Steven A. Wrighton and Jordan L. Holtzman
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 785-790;
  • You have access
    Interindividual Variability in Expression and Activity of Human β-Glucuronidase in Liver and Kidney: Consequences for Drug Metabolism
    Bernhard Sperker, Thomas E. Mürdter, Monika Schick, Klaus Eckhardt, Klaus Bosslet and Heyo K. Kroemer
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 914-920;

GASTROINTESTINAL PHARMACOLOGY

  • You have access
    Increased Intestinal Absorption of Cefixime by Nifedipine in the Rat Intestinal Perfusion Model: Evidence for a Neural Regulation
    L. Harcouët, D. Lebrec, C. Rozé, C. Carbon and R. Farinotti
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 738-745;

IMMUNOPHARMACOLOGY

  • You have access
    Losartan, a Selective Inhibitor of Subtype AT1 Receptors for Angiotensin II, Inhibits the Binding ofN-Formylmethionyl-leucyl-phenylalanine to Neutrophil Receptors
    Silvina Raiden, Mirta Giordano, Graciela Andonegui, Analía S. Trevani, Daniel H. López, Victor Nahmod and Jorge R. Geffner
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 624-628;
  • You have access
    Cysteinyl Leukotrienes Induce P-Selectin Expression in Human Endothelial Cells via a Non-CysLT1 Receptor-Mediated Mechanism
    Karen E. Pedersen, Bruce S. Bochner and Bradley J. Undem
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 655-662;
  • You have access
    A Peptidomimetic that Specifically Inhibits Human Leukocyte Antigen DRB1*0401-restricted T Cell Proliferation
    Susan L. Woulfe, Christine P. Bono, Michelle L. Zacheis, Joseph K. Welply, Dawn A. Kirschmann, Troy A. Baudino, Yang Wang, Deborah A. Stone, Gunnar J. Hanson, Jennifer L. Vuletich, Louis J. Bedell, Benjamin D. Schwartz and Susan C. Howard
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 663-669;
  • You have access
    Activation of the Alternative Pathway of Complement by a Phosphorothioate Oligonucleotide: Potential Mechanism of Action
    Scott P. Henry, Patricia C. Giclas, Janet Leeds, Michael Pangburn, Carol Auletta, Arthur A. Levin and Douglas J. Kornbrust
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 810-816;
  • You have access
    Activation of Mu Opioid Receptors Inhibits Microglial Cell Chemotaxis
    Chun C. Chao, Shuxian Hu, Katherine B. Shark, Wen S. Sheng, Genya Gekker and Phillip K. Peterson
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 998-1004;

NEUROPHARMACOLOGY

  • You have access
    Hippocampal Noradrenaline Release in Awake, Freely Moving Rats Is Regulated by Alpha-2 Adrenoceptors but Not by Adenosine Receptors
    Adrian J. Carter
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 648-654;
  • You have access
    Receptor Reserve and Turnover of Alpha-2 Adrenoceptors that Mediate the Clonidine-Induced Inhibition of Rat Locus Coeruleus Neurons In Vivo
    Joseba Pineda, J. Angel Ruiz-Ortega and Luisa Ugedo
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 690-698;
  • You have access
    Increased Responsiveness of Ventral Tegmental Area Dopamine Neurons to Glutamate after Repeated Administration of Cocaine or Amphetamine Is Transient and Selectively Involves AMPA Receptors
    Xu-Feng Zhang, Xiu-Ti Hu, Francis J. White and Marina E. Wolf
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 699-706;
  • You have access
    Pharmacological Characterization of 1-Aminoindan-1,5-dicarboxylic Acid, a Potent mGluR1 Antagonist
    Flavio Moroni, Grazia Lombardi, Christian Thomsen, Patrizia Leonardi, Sabina Attucci, Fiamma Peruginelli, Serenella Albani Torregrossa, Domenico E. Pellegrini-Giampietro, Roberto Luneia and Roberto Pellicciari
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 721-729;
  • You have access
    γ-Hydroxybutyrate Conversion into GABA Induces Displacement of GABAB Binding that is Blocked by Valproate and Ethosuximide
    Viviane Hechler, Charline Ratomponirina and Michel Maitre
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 753-760;
  • You have access
    Structure-Activity Relationships of a Series of [d-Ala2]Deltorphin I and II Analogues;in Vitro Blood-Brain Barrier Permeability and Stability
    Sarah A. Thomas, Thomas J. Abbruscato, Vincent S. Hau, Terrence J. Gillespie, Joseph Zsigo, Victor J. Hruby and Thomas P. Davis
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 817-825;
  • You have access
    Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models
    E. D. Hall, P. K. Andrus, S. L. Smith, T. J. Fleck, H. M. Scherch, B. S. Lutzke, G. A. Sawada, J. S. Althaus, P. F. Vonvoigtlander, G. E. Padbury, P.G. Larson, J. R. Palmer and G. L. Bundy
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 895-904;
  • You have access
    Effects of a Novel Free Radical Scavenger, MCI-186, on Ischemic Brain Damage in the Rat Distal Middle Cerebral Artery Occlusion Model
    Hiroshi Kawai, Hiroshi Nakai, Misao Suga, Satoshi Yuki, Toshiaki Watanabe and Ken-Ichi Saito
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 921-927;
  • You have access
    Age-Related Deficits in the Cerebellar BetaAdrenergic Signal Transduction Cascade in Fischer 344 Rats
    Thomas J. Gould and Paula C. Bickford
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 965-971;
  • You have access
    The Full D1 Dopamine Receptor Agonist SKF-82958 Induces Neuropeptide mRNA in the Normosensitive Striatum of Rats: Regulation of D1/D2 Interactions by Muscarinic Receptors
    John Q. Wang and Jacqueline F. McGinty
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 972-982;
  • You have access
    HepG2 and SK-N-MC: Two Human Models to StudyAlpha-2 Adrenergic Receptors of theAlpha-2C Subtype
    Stéphane Schaak, Cécile Cayla, Régis Blaise, Françoise Quinchon and Hervé Paris
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 983-991;

PROSTAGLANDINS, LEUKOTRIENES AND OTHER EICOSANOIDS

  • You have access
    Endothelin Receptor Antagonists: Effect of Serum Albumin on Potency and Comparison of Pharmacological Characteristics
    Jinshyun R. Wu-Wong, Douglas B. Dixon, William J. Chiou and Terry J. Opgenorth
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 791-798;
  • You have access
    FP Prostaglandin Receptors Mediating Inositol Phosphates Generation and Calcium Mobilization in Swiss 3T3 Cells: A Pharmacological Study
    B. W. Griffin, G. W. Williams, J. Y. Crider and N. A. Sharif
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 845-854;
  • You have access
    Thrombin Receptor-Activating Peptide Releases Arachidonic Acid from Human Platelets: A Comparison with Thrombin and Trypsin
    Archibald McNicol and Cameron A. Robson
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 861-867;
  • You have access
    Effects of the 5-Lipoxygenase Inhibitor A-64077 on Intestinal Hypothermic Organ Preservation Injury
    Martin J. Mangino, Janice E. Mangino, Bharat Kotadia and Marek Sielczak
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 950-956;
  • You have access
    The Human Thromboxane A2 Receptor α Isoform (TPα) Functionally Couples to the G Proteins Gq and G11 In Vivo and is Activated by the Isoprostane 8-epi Prostaglandin F2α
    B. Therese Kinsella, Daniel J. O’Mahony and Garret A. Fitzgerald
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 957-964;
  • You have access
    Prostaglandin E2 Production Dependent upon Cyclooxygenase-1 and Cyclooxygenase-2 and Its Contradictory Modulation by Auranofin in Rat Peritoneal Macrophages
    Masateru Yamada, Hisae Niki, Masamichi Yamashita, Suetsugu Mue and Kazuo Ohuchi
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 1005-1012;

TOXICOLOGY

  • You have access
    The Pyrethroids Permethrin and Cyhalothrin are Potent Inhibitors of the Mitochondrial Complex I
    Beat Gassner, Andreas Wüthrich, Günter Scholtysik and Marc Solioz
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 855-860;
  • You have access
    Expression of hygR in Transgenic Mice Causes Resistance to Toxic Effects of Hygromycin B In Vivo
    Jiri Aubrecht, Mary E. P. Goad, Elizabeth M. Simpson and Robert H. Schiestl
    Journal of Pharmacology and Experimental Therapeutics May 1997, 281 (2) 992-997;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 281, Issue 2
1 May 1997
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • ANALGESIA AND DRUGS OF ABUSE
  • AUTONOMIC PHARMACOLOGY
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR PHARMACOLOGY
  • CELLULAR AND MOLECULAR PHARMACOLOGY
  • DRUG METABOLISM AND DISPOSITION
  • GASTROINTESTINAL PHARMACOLOGY
  • IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • PROSTAGLANDINS, LEUKOTRIENES AND OTHER EICOSANOIDS
  • TOXICOLOGY
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics